Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1956 1
1958 3
1959 2
1961 1
1962 4
1963 4
1964 3
1965 4
1966 2
1967 5
1968 3
1969 7
1971 6
1972 4
1973 5
1974 3
1975 2
1978 3
1979 3
1980 1
1981 2
1982 3
1983 1
1984 1
1985 5
1986 7
1987 9
1988 7
1989 10
1990 12
1991 16
1992 18
1993 20
1994 23
1995 31
1996 41
1997 29
1998 30
1999 52
2000 37
2001 51
2002 63
2003 58
2004 78
2005 100
2006 121
2007 135
2008 160
2009 184
2010 232
2011 278
2012 295
2013 307
2014 374
2015 398
2016 446
2017 465
2018 552
2019 642
2020 734
2021 843
2022 1052
2023 1058
2024 1103
2025 1096
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,045 results

Results by year

Filters applied: . Clear all
Page 1
Atlas of the plasma proteome in health and disease in 53,026 adults.
Deng YT, You J, He Y, Zhang Y, Li HY, Wu XR, Cheng JY, Guo Y, Long ZW, Chen YL, Li ZY, Yang L, Zhang YR, Chen SD, Ge YJ, Huang YY, Shi LM, Dong Q, Mao Y, Feng JF, Cheng W, Yu JT. Deng YT, et al. Among authors: cheng w. Cell. 2025 Jan 9;188(1):253-271.e7. doi: 10.1016/j.cell.2024.10.045. Epub 2024 Nov 22. Cell. 2025. PMID: 39579765 Free article.
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. Among authors: cheng w. JAMA Cardiol. 2022 Oct 1;7(10):1000-1008. doi: 10.1001/jamacardio.2022.2695. JAMA Cardiol. 2022. PMID: 36001335 Free PMC article. Clinical Trial.
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L, Zhang Y, Shen S, Wang X, Dong L, Li Q, Ren W, Li Y, Bai J, Gong Q, Kuang H, Qi L, Lu Q, Cheng W, Liu Y, Yan S, Wu D, Fang H, Hou F, Wang Y, Yang Z, Lian X, Du J, Sun N, Ji L, Li G; China Diabetes Prevention Program Study Group. Zhang L, et al. Among authors: cheng w. Lancet Diabetes Endocrinol. 2023 Aug;11(8):567-577. doi: 10.1016/S2213-8587(23)00132-8. Epub 2023 Jul 3. Lancet Diabetes Endocrinol. 2023. PMID: 37414069 Clinical Trial.
10,045 results
You have reached the last available page of results. Please see the User Guide for more information.